Navigation Links
More Evidence Links Specific Genes to ADHD

SUNDAY, Dec. 4 (HealthDay News) -- Variations in genes involved in brain signaling pathways appear to be linked to attention-deficit/hyperactivity disorder (ADHD), according to a new study.

The findings suggest that drugs that act on these pathways may offer a new treatment option for ADHD patients with the gene variants, the Children's Hospital of Philadelphia researchers said.

In the study, researchers conducted whole-genome analyses of 1,000 children with ADHD and 4,100 children without ADHD. They then evaluated the findings in light of other research involving nearly 12,000 subjects -- 2,500 with ADHD and 9,200 without.

The genomic analysis revealed at least 10 percent of the children with ADHD had so-called "copy number variations" -- deletions or duplications of DNA sequences -- in four genes that are all part of the glutamate receptor gene family. The strongest result was in gene GMR5.

Glutamate is a neurotransmitter, a protein that transmits signals between neurons in the brain, the study authors explained in a hospital news release.

"Members of the GMR gene family, along with genes they interact with, affect nerve transmission, the formation of neurons, and interconnections in the brain, so the fact that children with ADHD are more likely to have alterations in these genes reinforces previous evidence that the GMR pathway is important in ADHD," study leader Dr. Hakon Hakonarson, director of the Center for Applied Genomics at Children's Hospital, said in the news release.

"Our findings get to the cause of the ADHD symptoms in a subset of children with the disease," he added.

One expert said the finding could prove to be significant.

"This study is important not only in that it has identified gene variants that are associated with ADHD in approximately 10 percent of cases, but it identifies novel treatment strategies related to the neurotransmitter glutamate that researchers can now try to develop for individuals with the newly identified gene variants," said Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at Steven & Alexandra Cohen Children's Medical Center of New York in New Hyde Park, N.Y.

"This study provides further evidence not only that ADHD has a genetic basis in a distinct subset of children with ADHD but that the neurotransmitter glutamate seems to play a big role in some cases," he added. "Hopefully, these findings will allow researchers to identify safe and effective treatment strategies for the subset of children with ADHD who have variations in their glutamate-related genes."

The study was published online Dec. 4 in the journal Nature Genetics.

ADHD affects as many as 7 percent of school-age children and a smaller percentage of adults. Symptoms include short attention span, impulsive behavior and excessive activity. The causes are not known, but ADHD tends to run in families and is believed to be influenced by many interacting genes.

Adesman also noted that the technique used in this study, comparative whole-genome analysis, "may in the future identify other treatment opportunities for sub-groups of children with ADHD and other conditions."

More information

The American Academy of Family Physicians has more about ADHD.

-- Robert Preidt

SOURCES: Andrew Adesman, M.D., chief, developmental and behavioral pediatrics, Steven & Alexandra Cohen Children's Medical Center of New York, New Hyde Park, N.Y.; Children's Hospital of Philadelphia, news release, Dec. 4, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. More Evidence That HPV Vaccine Shields Against Cervical Cancer
2. Evidence base for exercise programs for older people still in the balance
3. Weak evidence to support exercise referrals
4. Little Evidence of Heart Risks From ADHD Meds
5. More Evidence Shows Newer Forms of Pill Raise Clot Risk, FDA Says
6. Clinical trial shows first evidence that anal cancer is preventable
7. Researchers have found evidence for the existence of a hypnotic state
8. More Evidence Links Tanning Beds to Higher Skin Cancer Risk
9. Evidence-based medicine in health-care reform
10. More evidence that allergies may help in fighting brain tumors
11. Toronto researchers find first physical evidence bilingualism delays onset of Alzheimers symptoms
Post Your Comments:
Related Image:
More Evidence Links Specific Genes to ADHD
(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... WESTWOOD, Mass. , Oct. 4, 2017  According to the Centers ... by the end of October . PhysicianOne Urgent Care is helping communities ... Westchester, NY , by offering no-cost* flu shots through ... , as mandated by certain health insurance regulations. ... The best time to get a flu shot is by ...
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at ...
Breaking Medicine Technology: